Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct738 - measles (rubeola) virus ivds - for in vitro diagnostic use in testing clinical specimens to provide information about infection with, or exposure to, measles virus.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct356 - parasitic infectious diseases ivds - for in vitro diagnostic use in testing clinical specimens to provide information about the presence of, or infection with, one or a number of parasitic organisms, including protozoa, amoebae, nematodes and/or other worms.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct356 - parasitic infectious diseases ivds - immunoassays for the detection of exposure to parasitic infectious diseases.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct771 - rubella virus ivds - for in vitro diagnostic use in testing to provide information about infection with or exposure to rubella virus.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct820 - toxoplasma ivds - for in vitro diagnostic use in testing to provide information about the presence of, or infection with, the protozoan parasite toxoplasma gondii in clinical specimens.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct756 - varicella zoster virus (human herpesvirus 3) ivds - for in vitro diagnostic use in testing to provide information about infection with or exposure to the varicella zoster virus.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct756 - varicella zoster virus (human herpesvirus 3) ivds - for in vitro diagnostic use in testing to provide information about infection with or exposure to the varicella zoster virus (vzv).

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct355 - viral infectious disease ivds - for in vitro diagnostic use in testing clinical specimens to provide information about infection with, or exposure to, one or a number of viruses capable of causing disease.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct355 - viral infectious disease ivds - for in vitro diagnostic use in testing clinical specimens to provide information about infection with, or exposure to, one or a number of viruses capable of causing disease.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - 48315 - hepatitis b virus surface total antibody ivd, kit, enzyme immunoassay (eia) - a one-step assay based on the sandwich principle. inactivated hbsag is used as solid phase and as conjugate antigen. peroxidase-labelled hbsag binds to hbs-specific antibodies in the sample. these bind to the hbsag bound to the surface of the microtitration plate (antigen sandwich). the enzyme portion of the conjugate results in a blue colour. stopping this reaction causes colour change to yellow. intensity of yellow colour is proportional to the activity of specific antibody in sample. an enzyme immunoassay for the qualitative detection and quantitative determination of specific antibodies to the hepatitis b surface antigen (hbsag) in human serum and plasma.